Table 2.
Control Trial | Exercise Trial | P-value | |
---|---|---|---|
Fasting systolic BP, mmHg | 114 ± 4 | 115 ± 4 | 0.86 |
Fasting diastolic BP, mmHg | 66 ± 2 | 66 ± 2 | 0.89 |
Fasting glucose, mg/dL | 87 ± 2 | 84 ± 2 | 0.08 |
Glucose AUC, mg/dL · min | 16828 ± 689 | 15858 ± 689 | 0.16 |
Fasting insulin, µU/mL | 3.0 ± 0.3 | 2.6 ± 0.3 | 0.08 |
Insulin AUC, µU/mL · min | 3898 ± 518 | 3158 ± 518 | 0.12 |
Insulin sensitivity index | 9.2 ± 0.7 | 10.8 ± 0.7 | 0.01 |
HOMA-IR | 0.64 ± 0.06 | 0.54 ± 0.06 | 0.04 |
Fasting FMD, % | 4.7 ± 1.0 | 5.5 ± 1.0 | 0.31 |
FMD AUC, % · min | 607 ± 122 | 774 ± 122 | 0.01 |
Fasting TBARS, µmol/L | 13.0 ± 3.2 | 16.4 ± 3.2 | 0.40 |
TBARS AUC, µmol/L · min | 1735 ± 218 | 1733 ± 218 | 0.82 |
Data are means ± SEM and represent 13 subjects who underwent both the control and exercise treatments. P-value reflects the significance for the comparison between the control and exercise conditions, which were performed using one-factor (treatment) ANOVAs with repeated measures. AUC, area under the curve; BP, blood pressure; FMD, flow mediated dilation of the brachial artery; HOMA-IR, homeostasis model assessment of insulin resistance. Insulin sensitivity index is unitless and was determined according to Matsuda and DeFronzo (23) using all data from the 150-minute test. HOMA-IR is a unitless index and was calculated according to Matthews et al. (24). Mean postprandial FMD was calculated using data from all postprandial measures.